Cargando…
Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients
Carbamazepine (CBZ) is a widely used antiepileptic drug with large interindividual variability in serum concentrations. Previous studies found that CYP3A5∗3 (rs776746), UGT2B7∗2 (802C>T), and UGT2B7∗3 (211G>T) variants could change the enzymes’ activity, which may influence drug concentrations...
Autores principales: | Lu, Qiong, Huang, Yuan-Tao, Shu, Yi, Xu, Ping, Xiang, Da-Xiong, Qu, Qiang, Qu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078657/ https://www.ncbi.nlm.nih.gov/pubmed/30045320 http://dx.doi.org/10.1097/MD.0000000000011662 |
Ejemplares similares
-
The influence of CYP2C8*3 on carbamazepine serum concentration in epileptic pediatric patients
por: Milovanovic, DD, et al.
Publicado: (2016) -
Pharmacogenetics of CYP3A5 on Carbamazepine pharmacokinetics in epileptic patients developing toxicity
por: Al-Gahtany, Mubarak, et al.
Publicado: (2014) -
Effects of EPHX1 and CYP3A4 polymorphisms on carbamazepine metabolism in epileptic patients
por: Caruso, Antonietta, et al.
Publicado: (2014) -
Oxidative Status in Epileptic Children Using Carbamazepine
por: Tutanc, Murat, et al.
Publicado: (2015) -
SCN1A and SCN1B gene polymorphisms and their association with plasma concentrations of carbamazepine and carbamazepine 10, 11 epoxide in Iranian epileptic patients
por: Namazi, Soha, et al.
Publicado: (2015)